Prophylactic angiographic embolisation after endoscopic control of bleeding to high-risk peptic ulcers: a randomised controlled trial. Gut 2019; 68: 796-803
Published: 20th March 2020
Authors: Lau JYW, Pittayanon R, Wong K-T, Pinjaroen N, Chiu PWY, Rerknimitr R et al.
After the bleeding had been stopped by endoscopy, 241 patients were randomly allocated to additional angiographic embolization. The rate of rebleeding within 30 days was similar: hazard ratio 1.14, 95 per cent c.i.0.53 to 2.46. Embolisation only reduced rebleeding in patients with ulcers >15mm in diameter.Pubmed Link
You may also be interested in
Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study. Gut 2020; 69: 859–867.
Authors: El-Salhy M, Hatlebakk JG, Gilja OH, Kristoffersen AB, Hausken T
Luglio G, Rispo A, Imperatore N, Giglio MC, Amendola A, Tropeano FP et al. Surgical prevention of anastomotic recurrence by excluding mesentery in Crohn’s Disease: the SuPREMe-CD Study – A Randomized Clinical Trial. Ann Surg 2020; 272: 210-217.
Authors: Luglio G , Rispo A, Imperatore N, Giglio MC, Amendola A, Tropeano FP et al.
Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial. Lancet 2020; 395: 1927-1936.
Authors: The HALT-IT Trial Collaborators
A prospective randomized controlled trial of laparoscopic repair versus open repair for perforated peptic ulcers. Surgery 2016; 159: 451–458.
Authors: Ge B, Wu M, Chen Q, Chen Q, Lin R, Liu L et al.
Double oral esomeprazole after a 3-day intravenous esomeprazole infusion reduces recurrent peptic ulcer bleeding in high-risk patients: a randomised controlled study. Gut 2014; 63: 1864-1872.
Authors: Cheng HC, Wu CT, Chang WL, Cheng WC, Chen VVY, Sheu BS et al.
Multinational, double-blind, randomised, placebo controlled, prospective study of esomeprazole in the prevention of recurrent peptic ulcer in low-dose acetylsalicylic acid users: the LAVENDER study. Gut 2014; 63: 1061-1068.
Authors: Sugano K, Choi M-G, Lin J-T, Goto S, Okada Y, Kinoshita Y et al. et al.
Enhanced postoperative recovery pathways in emergency surgery: a randomised clinical trial. Am J Surg 2014; 207: 807-814.
Authors: Gonenc M, Dural AC, Celik F, Akarsu C, Kocatas A, Kalayci MU et al. et al.
Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice. Gut 2014; 63: 244-249.
Authors: McNicholl AG, Marin AC, Molina-Infante J, Castro M, Barrio G, Ducons J et al. et al.
Authors: Villanueva C, Colomo A, Bosch A, Concepcion M, Hernandez-Gea V, Aracil C et al. et al.
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. Lancet 2012; 381: 205–213.
Authors: Liou JM, Chen CC, Chen MJ, Chen CC, Chang CY, Fang YJ et al. et al.
Randomized clinical trial of vessel sealing system (LigaSure) in esophagogastric devascularisation and splenectomy in patients with portal hypertension. Am J Surg 2011; 41: 82-90.
Authors: Yao SH, Wang WJ, Wang Q, Gao WC, Xiang HG, Hu ZQ et al. et al.
Novel approach to antibiotic prophylaxis in percutaneous endoscopic gastrostomy (PEG): randomised controlled trial. BMJ 2010; 340: 81.
Authors: Blomberg J, Lagergren P, Martin L, Mattsson F, Lagergren J.